RGEN Q2 2020 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q2 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$87M+23.7% YoY

Gross Profit

$51M57.9% margin

Operating Income

$20M22.3% margin

Net Income

$16M18.1% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

+14.9%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$342M

Stockholders' Equity

$1.1B

Cash & Equivalents

$560M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$71M	+23.7%
Gross Profit	$51M	$40M	+26.5%
Operating Income	$20M	$11M	+76.7%
Net Income	$16M	$8M	+95.9%

Revenue Segments

Product

$87M100%

Royalty

$30,0000%